Skip to main content
. 2023 Sep 1;4(9):101187. doi: 10.1016/j.xcrm.2023.101187

Table 2.

Endocrine and glycemic characteristics of children with LEP, LEPR, and MC4R mutations and lean controls

Characteristic LEP deficient LEPR deficient MC4R deficient Controls
Leptin, ng/mL (n) 0.1 ± 0.0a,b (108) 31.9 ± 2.7c,d (49) 26.7 ± 3.5c,d (26) 3.1 ± 0.1a,b (68)
Insulin, μIU/mL (n) 24.6 ± 2.3a,b,d (111) 41.8 ± 5.9c,d (49) 49.0 ± 10.3c,d (26) 6.9 ± 0.5a,b,c (61)
Cortisol, μg/dL (n) 16.2 ± 0.8a,b,d (111) 13.3 ± 0.7c,d (49) 10.9 ± 0.8c (26) 9.4 ± 0.3a,c (61)
TSH, μIU/mL (n) 2.2 ± 0.1 (112) 2.3 ± 0.2 (49) 2.1 ± 0.2 (26) 2.2 ± 0.1 (61)
HbA1C (n) 5.2 ± 0.1d (29) 5.0 ± 0.1b,d (19) 5.9 ± 0.5a,d (7) 4.2 ± 0.1a,b,c (40)
RBG∗, mg/dL (n) 95.7 ± 3.2 (30) 99.7 ± 3.7 (23) 109.1 ± 7.8 (15) 102.8 ± 2.6 (40)
T4, μg/dL (n) 8.4 ± 0.6 (23) 7.0 ± 0.5 (11) 7.6 ± 0.9 (15) 8.1 ± 0.3 (27)
T3, ng/mL (n) 1.8 ± 0.1 (23) 1.9 ± 0.2 (11) 1.6 ± 0.1 (15) 1.5 ± 0.1 (27)

Data represent mean ± SEM.

∗Random blood glucose

a

Statistically significant p <0.05 (Scheffe’s multiple test) vs. LEPR deficient.

b

Statistically significant p <0.05 (Scheffe’s multiple test) vs. MC4R deficient.

c

Statistically significant p <0.05 (Scheffe’s multiple test) vs. LEP deficient.

d

Statistically significant p <0.05 (Scheffe’s multiple test) vs. controls.